Inflammatory mediator contributes to leptin resistance and obesity in craniopharyngioma
The FASEB Journal · 2024
DOI: 10.1096/fj.202402216rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Youchao Xiao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Ningbo University, Zhejiang, China. Hauptthemen laut MEDLINE: Leptin, Obesity, Chemokine CXCL1, Craniopharyngioma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Beijing Municipal Science and Technology Commission, Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support, Ningbo Top Medical and Health Research Program.
Abstract (Originalsprache)
Obesity presents a significant challenge in managing patients with craniopharyngioma (CP). Cyst fluid (CF), rich in inflammatory mediators, is implicated in CP‐related obesity, though the precise mechanism remains unclear. This study investigated the impact of CF or C‐X‐C motif chemokine ligand‐1 (CXCL1) injections on body weight, Lee index, plasma lipid profiles, hepatic lipid accumulation, leptin levels, NF‐κB pathway, the suppressor of cytokine signaling 3 (SOCS3) expression, and leptin sensitivity in rats. Bioinformatics was employed to identify differentially expressed genes (DEGs) between CF/CXCL1‐treated and control SY5Y cells, as well as to confirm enriched pathways. Western blotting was used for experimental validation, including the effects of sodium salicylate (SS) on leptin sensitivity in SY5Y cells. Injecting CF or CXCL1 into the brain, without hypothalamic damage, led to increased body weight, Lee index, and hepatic lipid accumulation in rats, alongside elevated fasting blood glucose, triglycerides, and total cholesterol, while high‐density lipoprotein cholesterol levels decreased. Additionally, CF and CXCL1 could induce elevated leptin levels, a higher leptin‐to‐body weight ratio, and resistance to exogenous leptin by activating the NF‐κB pathway and upregulating the expression of SOCS3 in rats. Further validation confirmed that CF and CXCL1 suppress leptin signaling by activating the NF‐κB pathway and upregulating SOCS3. Moreover, SS mitigated the inhibitory effects of CF or CXCL1 on leptin signaling, preserving leptin sensitivity in SY5Y cells. These results highlight the obesogenic role of CF and CXCL1, offering insights into the development of morbid obesity through inflammatory factor‐mediated leptin resistance, independent of hypothalamic damage. SS may serve as a promising therapeutic approach for CP‐associated obesity, though additional clinical studies are necessary to confirm its efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Affiliated Hospital of Ningbo University, Zhejiang, China.
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Youchao Xiao, Wentao Wu, Fangzheng Liu, Lu Jin, Yanfei Jia, Ning Qiao, Kefan Cai, Siming Ru, Lei Cao, Songbai Gui
Förderung
- Beijing Municipal Science and Technology Commission
- Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support
- Ningbo Top Medical and Health Research Program
- Zhejiang Province Medical and Health Science and Technology Project
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
Zitieren
APA
Xiao, Y., Wu, W., Liu, F., Jin, L., Jia, Y., Qiao, N., Cai, K., Ru, S., Cao, L., & Gui, S. (2024). Inflammatory mediator contributes to leptin resistance and obesity in craniopharyngioma. The FASEB Journal. https://doi.org/10.1096/fj.202402216rr
Vancouver
Xiao Y, Wu W, Liu F, Jin L, Jia Y, Qiao N, et al. Inflammatory mediator contributes to leptin resistance and obesity in craniopharyngioma. The FASEB Journal. 2024. doi:10.1096/fj.202402216rr
BibTeX
@article{Xiao2024,
author = {Xiao, Youchao and Wu, Wentao and Liu, Fangzheng and Jin, Lu and Jia, Yanfei and Qiao, Ning and Cai, Kefan and Ru, Siming and Cao, Lei and Gui, Songbai},
title = {Inflammatory mediator contributes to leptin resistance and obesity in craniopharyngioma},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202402216rr}
}
EUVIMED